Evaluation of potential drug-drug interactions with medical cannabis
Abstract Cannabis-drug interactions have caused significant concerns, mainly due to their role in the cytochrome P450 (CYP) enzyme‐mediated metabolic pathway of numerous medications. A systematic review was conducted to gain an overview of the potential interactions of cannabis with different drug c...
Saved in:
Main Authors: | Jessie Jia Yi Ho (Author), Chenyi Goh (Author), Caitlin Shen Ai Leong (Author), Khuen Yen Ng (Author), Athirah Bakhtiar (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: Medical cannabis-warfarin drug-drug interaction
by: Tyan F. Thomas, et al.
Published: (2022) -
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
by: Rahul Nachnani, et al.
Published: (2024) -
Drug-drug interactions and potentially inappropriate medications among elderly outpatients
by: Atrianfar Fatemeh, et al.
Published: (2021) -
Study design considerations to assess the impact of potential drug-drug interactions in first‐in‐human studies in oncology drug development
by: Sriram Subramaniam, et al.
Published: (2023) -
Are there any potential drug-drug interactions with oral inhaler medications?: A retrospective study
by: Songul Tezcan, et al.
Published: (2024)